Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia – systematic review and meta-analysis of randomised controlled trials
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia – systematic review and meta-analysis of randomised controlled trials
Authors
Keywords
-
Journal
ACTA ONCOLOGICA
Volume 52, Issue 1, Pages 18-29
Publisher
Informa UK Limited
Online
2012-08-09
DOI
10.3109/0284186x.2012.702921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron
- (2011) David H. Henry et al. AMERICAN JOURNAL OF HEMATOLOGY
- Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials
- (2011) Fausto Petrelli et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Too-Low Iron Doses and Too Many Dropouts in Negative Iron Trial?
- (2011) Matti Aapro et al. JOURNAL OF CLINICAL ONCOLOGY
- Subgroups of Advanced Cancer Patients Clustered by Their Symptom Profiles: Quality-of-Life Outcomes
- (2011) Amna Husain et al. JOURNAL OF PALLIATIVE MEDICINE
- Parenteral Iron Therapy in Cancer-Associated Anemia
- (2011) D. H. Henry Hematology-American Society of Hematology Education Program
- Erythropoiesis-stimulating agents in cancer patients: reflections on safety
- (2011) Isabelle Wauters et al. Expert Review of Clinical Pharmacology
- Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy-induced anemia
- (2010) Michael Auerbach et al. AMERICAN JOURNAL OF HEMATOLOGY
- Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use
- (2010) D. Schrijvers et al. ANNALS OF ONCOLOGY
- Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy
- (2010) Penkae Dangsuwan et al. GYNECOLOGIC ONCOLOGY
- American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer
- (2010) J. Douglas Rizzo et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia
- (2010) David P. Steensma et al. JOURNAL OF CLINICAL ONCOLOGY
- Pooled Analysis of Individual Patient-Level Data From All Randomized, Double-Blind, Placebo-Controlled Trials of Darbepoetin Alfa in the Treatment of Patients With Chemotherapy-Induced Anemia
- (2009) Heinz Ludwig et al. JOURNAL OF CLINICAL ONCOLOGY
- Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
- (2009) Julia Bohlius et al. LANCET
- Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: Systematic Review and Meta-analysis
- (2008) Benaya Rozen-Zvi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia
- (2008) Charles L. Bennett JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
- (2008) Robert E. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced Anemia
- (2008) Laurent Bastit et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Intravenous Iron Supplementation in Patients With Chemotherapy-Related Anemia Without Iron Deficiency Treated With Darbepoetin Alfa
- (2008) Paolo Pedrazzoli et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of iron supplementation during epoietin treatment for cancer-related anemia
- (2008) M. Hedenus et al. MEDICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation